Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 8.
Article
Ali, N;
Flutter, B;
Sanchez Rodriguez, R;
Sharif-Paghaleh, E;
Barber, LD;
Lombardi, G;
Nestle, FO;
(2012)
Xenogeneic graft-versus-host-disease in NOD-scid IL-2Rγnull mice display a T-effector memory phenotype.
PLoS One
, 7
(8)
, Article e44219. 10.1371/journal.pone.0044219.
|
 |
|
Capsomidis, A;
Benthall, G;
Van Acker, HH;
Fisher, J;
Kramer, AM;
Abeln, Z;
Majani, Y;
... Anderson, J; + view all
(2017)
Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation.
Molecular Therapy
10.1016/j.ymthe.2017.12.001.
(In press).
|
 |
|
Fisher, J;
Abramowski, P;
Wisidagamage Don, ND;
Flutter, B;
Capsomidis, A;
Cheung, GW-K;
Gustafsson, K;
(2017)
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor.
Molecular Therapy
, 25
(3)
pp. 1234-1247.
10.1016/j.ymthe.2017.03.002.
|
|
|
Fisher, JPH;
Flutter, BR;
Wesemann, F;
Frosch, J;
Rossig, C;
Gustafsson, K;
Anderson, J;
Effective combination treatment of GD2-expressing neuroblastoma and Ewing's sarcoma using anti-GD2 ch14.18/CHO antibody with Vγ9Vδ2+ γδT cells.
OncoImmunology
, 5
(1)
, Article e1025194. 10.1080/2162402X.2015.1025194.
|
|
|
Khan, AB;
Carpenter, B;
Sousa, PSE;
Pospori, C;
Khorshed, R;
Griffin, J;
Veliça, P;
... Chakraverty, R; + view all
(2018)
Redirection to the bone marrow improves T cell persistence and antitumor functions.
The Journal of Clinical Investigation
, 128
(5)
pp. 2010-2024.
10.1172/JCI97454.
|
|
|
Ollé Hurtado, M;
Wolbert, J;
Fisher, J;
Flutter, B;
Stafford, S;
Barton, J;
Jain, N;
... Anderson, J; + view all
(2019)
Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function.
PLoS One
, 14
(8)
, Article e0216373. 10.1371/journal.pone.0216373.
|
|
|
Philip, B;
Kokalaki, E;
Mekkaoui, L;
Thomas, S;
Straathof, K;
Flutter, B;
Marin, V;
... Pule, M; + view all
(2014)
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy.
Blood
, 124
(8)
1277 - 1287.
10.1182/blood-2014-01-545020.
|
|
Straathof, K;
Flutter, B;
Wallace, R;
Jain, N;
Loka, T;
Depani, S;
Wright, G;
... Anderson, J; + view all
(2020)
Anti-tumor activity without on-target off-tumor toxicity of GD2-Chimeric Antigen Receptor T cells in patients with neuroblastoma.
Science Translational Medicine
, 12
(571)
, Article eabd6169. 10.1126/scitranslmed.abd6169.
|
